Table 4. AAV9 preparations.
| Vector name | Serotype | Cell density at time of transfection (live cells/mL) | Viability at time of transfection | Titer from 90 mL cell suspension culture (vg/mL) | Total particles from 90 mL cell suspension culture (vg) | |
|---|---|---|---|---|---|---|
| AV0-EF1-N-cG | AAV9 | 1.6 × 106 | 97% | 8.24 × 1013 | 1.65 × 1013 | |
| AV0-EF1-N-cG | AAV9 | 1.3 × 106 | 97% | 1.04 × 1014 | 2.08 × 1013 | |
| AV0-EF1-N-cG | AAV9 | 1.3 × 106 | 97% | 6.15 × 1013 | 1.23 × 1013 | |
| AV0-EF1-N-tdT | AAV9 | 1.4 × 106 | 86% | 6.18 × 1013 | 1.23 × 1013 | |
| AV0-EF1-N-tdT | AAV9 | 1.1 × 106 | 87% | 6.23 × 1013 | 1.25 × 1013 | |